| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.26 | 0.09 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.03 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.17 | 0.3 |